Vigilent Labs (v.LABS)

Vigilent Labs has assembled a team of experts that bring a depth of expertise and knowledge in the diagnostic, medical and surveillance markets. With over 100 years of combined science, regulatory and government relations experience, Vigilent offers a single source for the spectrum of COVID-19 testing, including SARS-CoV-2 antibody, antigen, and molecular diagnostics. With current and new partnerships Vigilent Labs’vision is to offer communities a complete answer to the COVID-19 pandemic and future health events.

Addressable Markets

Vigilent Labs Production Facilities

Creating A Digital All Clear Pass: v.PASS

The v.LABS Platform has been designed as a digital, hand-held, point-of-test, Lateral Flow Immuno-Assay (“LFIA”) identification and detection device.

Partnership Opportunities